# G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer

> **NCT00554463** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 5 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Pegfilgrastim
- **DRUG:** Etoposide
- **DRUG:** Cisplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00554463
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-08-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554463, "G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00554463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*